Emyria’s real-world data mission and drug development programs feature in this comprehensive guide to the Australian Biotech industry featured in the Australian newspaper in tandem with Stockhead.

There are lots of great stories in here on our burgeoning industry, but if you’re keen on an overview on Emyria, turn to page 24.

Read more: https://www.theaustralian.com.au/business/stockhead/investor-guides